United States · 
What does 5AM Ventures invest in?
5AM Ventures invests most often at Series A and Series B (62% of the rounds on record), in sectors such as Biopharmaceuticals, Biotechnology and Drug_delivery.
5AM Ventures highlights
- 01
9 cheques in the last 12 months
- 02
Mostly Series A and Series B: 62% of its rounds
- 03
Sole investor in 13 rounds, median $13M
- 04
10 exits from the portfolio
What they do
We’re a life science venture capital firm founded in 2002.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- BiopharmaceuticalsBiotechnologyDrug_delivery
- Based in
- San Francisco, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first147 appearances
- 2026
7 rounds
- Oct
- Jun
- Jun
- Jan
- Jan
- Jan
- Jan
- 2025
9 rounds
- Dec
- Nov
- Jul
- Jul
- Jul
- May
- Mar
- Mar
- Feb
- 2024
12 rounds
- Sept
- Aug
- Jul
- Jul
- Jul
- Jun
- Jun
- May
- May
- Apr
- Mar
- Jan
- 2023
5 rounds
- Nov
- Sept
- Aug
- May
- Jan
- 2022
4 rounds
- Nov
- Sept
- Aug
- Apr
- 2021
4 rounds
- Dec
- Aug
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration6 named
AJAndrew James SchwabMember, 5Am Venture Management LLCiForm ADV
JDJohn David DiekmanExecutive OfficeriFiling they signed
KMKush M. ParmarMember, 5Am Venture Management, LLCiForm ADV
LALauren Alison DanielChief Compliance OfficeriForm ADV
PAPaul A StonePartner, Chief Legal OfficeriForm ADV
SMScott Michael RocklageExecutive OfficeriFiling they signed
We also hold 39 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$1.1Bassets it managesOct 2026
5+funds on filenumbered funds in its name
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- 5am Venture Management, LLC
- SEC number
- CRD 160395
Funds on its Form ADV
11 private funds, $1.5B in gross assets · filed Nov 2024
Venture 9Private equity 2
- 5AM Ventures VII, L.P.Venture106 investors$413M
- 5AM Ventures VI, L.P.Venture87 investors$376M
- 5AM Opportunities II, L.P.Private equity86 investors$320M
- 5AM Ventures V, L.P.Venture81 investors$150M
- 5AM Ventures IV, L.P.Venture50 investors$82M
- 5AM Opportunities I, L.P.Private equity49 investors$68M
- 5AM Ventures II, L.P.Venture45 investors$27M
- 5AM Ventures III, L.P.Venture45 investors$14M
- 5AM Co-Investors IV, L.P.Venture33 investors$3.4M
- 5AM Co-Investors II, L.P.Venture31 investors$1.1M
And 1 more on the filing.
Exits from the portfolio
Companies it backed that were later bought or listed10 in all
Novira TherapeuticsBought by Johnson & JohnsonUndisclosedNov 2015
CalibriumBought by Novo NordiskUndisclosedAug 2015
IkariaBought by Mallinckrodt$2.3BMar 2015
DVS SciencesBought by Fluidigm$208MJan 2014
Pearl TherapeuticsBought by AstraZeneca$1.1BJun 2013
KaloBios PharmaceuticalsListedUndisclosedJan 2013
Incline TherapeuticsBought by The Medicines CompanyUndisclosedDec 2012
Semprus BioSciencesBought by Teleflex$30MJun 2012
Synosia TherapeuticsBought by Biotie Therapies$122MJan 2011
Marcadia BiotechBought by RocheUndisclosedDec 2010
An exit counts when it came after the firm's first round in the company. From historical deal records.